Page 14 - Read Online
P. 14

Page 8 of 10                        Sebastián-Tomás et al. Mini-invasive Surg 2019;3:30  I  http://dx.doi.org/10.20517/2574-1225.2019.29

               5.   Leonard D, Penninckx F, Laenen A, Kartheuser A; Procare. Scoring the quality of total mesorectal excision for the prediction of
                   cancer-specific outcome. Colorectal Dis 2015;17:O115-22.
               6.   Kitz J, Fokas E, Beissbarth T, Strobel P, Wittekind C, et al. Association of plane of total mesorectal excision with prognosis of rectal
                   cancer: secondary analysis of the CAO/ARO/AIO-04 Phase 3 randomized clinical trial. JAMA Surg 2018;153:e181607.
               7.   Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, et al. Patterns of local recurrence in rectal cancer; a study of the
                   Dutch TME trial. Eur J Surg Oncol 2010;36:470-6.
               8.   Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol
                   2008;26:303-12.
               9.   Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, et al. Rates of circumferential resection margin involvement vary between
                   surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-57.
               10.  Garcia-Granero E, Faiz O, Munoz E, Flor B, Navarro S, et al. Macroscopic assessment of mesorectal excision in rectal cancer: a useful
                   tool for improving quality control in a multidisciplinary team. Cancer 2009;115:3400-11.
               11.  van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II):
                   short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210-8.
               12.  Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, et al. Open versus laparoscopic surgery for mid or low rectal cancer after
                   neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol
                   2010;11:637-45.
               13.  Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery
                   in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718-26.
               14.  Martinez-Perez A, Carra MC, Brunetti F, de’Angelis N. Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal
                   cancer: A systematic review and meta-analysis. World J Gastroenterol 2017;23:7906-16.
               15.  Fleshman J, Branda M, Sargent DJ, Boller AM, George V, et al. Effect of laparoscopic-assisted resection vs open resection of Stage II
                   or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
               16.  Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, et al. Effect of laparoscopic-assisted resection vs open resection on
                   pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314:1356-63.
               17.  Martinez-Perez A, Carra MC, Brunetti F, de’Angelis N. Pathologic outcomes of laparoscopic vs open mesorectal excision for rectal
                   cancer: a systematic review and meta-analysis. JAMA Surg 2017;152:e165665.
               18.  Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, et al. Disease-free survival and local recurrence for laparoscopic
                   resection compared with open resection of Stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized
                   controlled trial. Ann Surg 2019;269:589-95.
               19.  Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, et al. Disease-free survival and local recurrence after laparoscopic-
                   assisted resection or open resection for rectal cancer: the australasian laparoscopic cancer of the rectum randomized clinical trial. Ann
                   Surg 2019;269:596-602.
               20.  Martinez-Perez A, de’Angelis N. Comment on “Mid-term results of ACOSOG Z6051 trial sustain the unresolved debate”. Ann Surg
                   2019;270:e52-3.
               21.  Petrucciani N, Martinez-Perez A, Bianchi G, Memeo R, Brunetti F, et al. The use of laparoscopy for locally advanced rectal cancer.
                   Minerva Chir 2018;73:77-92.
               22.  de’Angelis N, Lizzi V, Azoulay D, Brunetti F. Robotic versus laparoscopic right colectomy for colon cancer: analysis of the initial
                   simultaneous learning curve of a surgical fellow. J Laparoendosc Adv Surg Tech A 2016;26:882-92.
               23.  Ahmed J, Nasir M, Flashman K, Khan J, Parvaiz A. Totally robotic rectal resection: an experience of the first 100 consecutive cases.
                   Int J Colorectal Dis 2016;31:869-76.
               24.  de’Angelis N, Portigliotti L, Azoulay D, Brunetti F. Robotic surgery: a step forward in the wide spread of minimally invasive
                   colorectal surgery. J Minim Access Surg 2015;11:285-6.
               25.  de’Angelis N, Portigliotti L, Brunetti F. Robot-assisted rectal cancer surgery deserves a fair trial. Colorectal Dis 2015;17:824-5.
               26.  Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of
                   conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. Jama
                   2017;318:1569-80.
               27.  Liao G, Zhao Z, Deng H, Li X. Comparison of pathological outcomes between robotic rectal cancer surgery and laparoscopic rectal
                   cancer surgery: A meta-analysis based on seven randomized controlled trials. Int J Med Robot 2019;15:e2027.
               28.  Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, et al. Robotic versus laparoscopic minimally invasive surgery for rectal cancer:
                   a systematic review and meta-analysis of randomized controlled trials. Ann Surg 2018;267:1034-46.
               29.  Jones K, Qassem MG, Sains P, Baig MK, Sajid MS. Robotic total meso-rectal excision for rectal cancer: a systematic review following
                   the publication of the ROLARR trial. World J Gastrointest Oncol 2018;10:449-64.
               30.  Rausa E, Bianco F, Kelly ME, Aiolfi A, Petrelli F, et al. Systemic review and network meta-analysis comparing minimal surgical
                   techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes. J Surg Oncol
                   2019;119:987-98.
               31.  Diana M, Marescaux J. Robotic surgery. Br J Surg 2015;102:e15-28.
               32.  George EI, Brand TC, LaPorta A, Marescaux J, Satava RM. Origins of robotic surgery: from skepticism to standard of care. JSLS
                   2018;22:e2018.00039.
               33.  Bargar WL, Bauer A, Borner M. Primary and revision total hip replacement using the robodoc system. Clin Orthop Relat Res
   9   10   11   12   13   14   15   16   17   18   19